User
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec Technology & Trading (Shanghai) Co., Ltd.
Room 2309
No. 319, Xianxia Road
Changning District
200051 Shanghai
P.R. China
Phone: +86 21 62351005
Fax: +86 21 62350953
E-Mail: macs@miltenyibiotec.com.cn
Web: www.miltenyibiotec.com
For immediate technical support, use our live chat. Connect with us
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
This December, Miltenyi Biotec once again hosted the unique CARAT training event on GMP-compliant CAR T cell manufacturing at the company’s headquarter in Germany.
After the first successful training of its kind in 2017, this year’s event sparked an even greater interest, attracting many scientists from all around the world to apply for participation. During the five-day training course, the five selected attendees were able to gain comprehensive insights into practical, regulatory, as well as scientific aspects of CAR T cell production. The goal of the training was to enable trainees to independently perform automated manufacture of cellular products, while being able to handle common process steps including GMP logistics, monitoring, and troubleshooting.
Therefore, the course covered an introduction to Miltenyi Biotec’s cell separation technology, the CliniMACS Prodigy® System, and the T cell transduction (TCT) process. The attendees learned all about the different process phases from cell selection and activation to transduction and expansion. Besides gaining familiarity with the process and the instrument itself, the scientists also learned about regulatory requirements, including trial design, approval, and the preparation of Investigational Medicinal Product Dossiers (IMPD). As part of the training, a guided tour of Miltenyi Biotec’s premises including its in-house cell factory facility provided firsthand insights into the company’s GMP activities, instrumentation, and reagents for clinical trials.
Once again, the CARAT training event was a unique mix of learning, sharing, and networking, while providing both conceptual and applied knowledge. Extensive hands-on exercises and open exchange of knowledge helped to quickly deepen the attendees’ expertise.
Related documents:
Play video
